Stargardt Disease Clinical Trials in Phoenix, Arizona

4 studies are recruiting for stargardt disease in Phoenix, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of ALK-001 on the Progression of Stargardt Disease

    This study evaluates the efficacy and safety of investigational study drug ALK-001 in participants 8 to 45 years of age, inclusive, with symptoms and signs of autosomal recessive Stargardt disease (STGD)

    Stage
    Phase 3
    Ages
    8 to 45
    Site
    Associated Retina Consultants, Phoenix, Arizona
    Locations
    14 in total
    Run by
    Alkeus Pharmaceuticals, Inc.

    See if you can join NCT07419334 on ClinicalTrials.gov

  2. A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

    Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the back of the eye. In people with macular dystrophies, some of the cells in the macula gradually stop working and may die over time. This lead…

    Stage
    Phase 1
    Ages
    6 and older
    Site
    Associated Retina Consultants, Phoenix, Arizona
    Locations
    3 in total
    Run by
    Astellas Institute for Regenerative Medicine

    See if you can join NCT07734064 on ClinicalTrials.gov

  3. A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

    Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the back of the eye. In people with macular dystrophies, some of the cells in the macula gradually stop working and may die over time. This lead…

    Stage
    Not phased
    Ages
    6 and older
    Site
    Associated Retina Consultants, Phoenix, Arizona
    Locations
    15 in total
    Run by
    Astellas Pharma Global Development, Inc.

    See if you can join NCT07425574 on ClinicalTrials.gov

  4. A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

    The purpose of the 039-101 study is to evaluate the safety and tolerability of a single subretinal injection of AAVB-039 in participants with Stargardt disease secondary to a biallelic mutation of the ABCA4 gene. The study will also assess initial efficacy following AAVB-039 administration.

    Stage
    Phase 1
    Ages
    8 to 55
    Site
    Associated Retina Consultants, Phoenix, Arizona
    Locations
    9 in total
    Run by
    AAVantgarde Bio Srl

    See if you can join NCT07161544 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.